Abcellera Biologics Inc ABCL

$11.80 -0.88 (-6.94%)

Valuation

Market cap
3,792,778,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
4,102,100
Avg volume
7,199,298
Day's range
$11.72 – $12.68
Shares out
306,611,000
Stochastic %K
35%
Beta
1.41
Analysts
Strong Sell
Price target
$16.82

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

dick3 Oct 16, 8:21 PM
$ABCL 93+% positive data for hot 🔥 flashes.. more data for menopausal women maybe also help sleep
0 replies
Stocktradesmoon Oct 16, 8:13 PM
$ABCL $MRNA Listen!!! Buy After Hours or REGRET it!! Any Doubt Listen to Carl CEO Cantor Conference Call 📞 best 30Minutes call I have EVER LISTENED too!!! ⏰ The best decision you will EVER Make!!! Next week EVENT is going to be 🔥!!! I’m expecting news after hours today ON 575 or early next week 💯 before 2026 TMS Conference !! They will be releasing the Phase II 12 Week DATA 📊 which will SEND us $18-$20’ss!!! I Can’t Wait!! Is it Monday Yet!!! 😆!!!
0 replies
Stocktradesmoon Oct 16, 8:04 PM
$ABCL 🔥 Biotech is the next memory. And now imagine $ABCL with the market cap of $MRNA And of course… well, it keeps going up $ABCL. If the executives and CFO themselves are telling you with their actions what you need to do. Well, the one who catches on does it. And as a Reminder, the IPO was in December at $20 and on the first day it closed at $77. 😮 🤯 Zero doubt that it will surpass those levels‼️ This is peak macro uncertainty: rates, bond yields, inflation and war. The market is trading headlines instead of businesses. But this will pass! I’m Loading! Eventually, investors will go back to caring about contracts, revenue, clinical data and execution not what the Fed, bonds or the next geopolitical headline might do. We are going GLOBAL. Hansen’s vision for $ABCL is playing out in real time. Love this company & happy to be an Owner! 🚨Carl is locked in...we don’t have enough shares. He basically laughed off phase3 not being successful... It’s green lights ahead baby
0 replies
Baazigar123 Oct 16, 7:56 PM 0 replies
Stocktradesmoon Oct 16, 7:56 PM
$ABCL AbCellera 🔥 🔥 It’s confusing how people who are convinced the market is headed much higher keep hoping for a deep pullback. They’re re bullish because the market is strong, so why would they want it to show weakness before they buy? ✅ The better outcome is a market that never gives the dip and leaves everyone waiting on the sidelines. ✅ Those locked-out buyers eventually have to chase, and thats the fuel that pushes prices much higher...
0 replies
Stocktradesmoon Oct 16, 7:52 PM
$ABCL Get in Now! Or be left OUT! $13-$14’ss Coming!! KNOWLEDGE is POWER! I have DONE ✅ MY Due Diligence $ABCL 🔥!!! • Fastest company ever to deliver an antibody drug against a new viral target – COVID-19. • 14 partner-initiated molecules already in the clinic with downstream economics. • Huge partnered pipeline behind those clinical programs. • Growing internal pipeline with multiple wholly owned programs moving toward the clinic. • ABCL635 just delivered the first major clinical validation of the internal platform. • 83% reduction in hot flash frequency vs 33% placebo. • Strong balance sheet, now strengthened by another $200M. • World-class infrastructure built to discover, develop and manufacture antibodies under one roof. • Years of investment are finally moving from building the platform → producing clinical assets. • This is JUST the Beginning!!
0 replies
Stocktradesmoon Oct 16, 7:48 PM
$ABCL Do you know how many are going to be joining after today? Many groups are going to be Alerted to get in!! Can imagine the millions of people who will know and learn about us after the 2026 TMS Menopause Convention Conference in 3 days!!! Yea rest assured we going to $18-$23’sss!! And then if we get news after hours today! BOOM!! 🤯
0 replies
erpy Oct 16, 7:34 PM
$ABCL Next up jmho
0 replies